BIOMAT Database Logo BIOMAT Database Logo

[Reactogenic and immunogenic properties of an attenuated strain of chicken pox virus]. 1969

V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007271 Injections, Intradermal The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer. Intradermal Injections,Injection, Intradermal,Intradermal Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D002644 Chickenpox A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed) Varicella,Chicken Pox
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol

Related Publications

V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
[Reactogenic and immunogenic properties of an attenuated strain of varicella virus].
January 1969, Voprosy virusologii,
V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
[The variability of tick-borne encephalitis virus. 7. Reactogenic and immunogenic properties of attenuated strain I-40 D upon oral vaccination of volunteers].
January 1970, Voprosy virusologii,
V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
[Results of investigation of infectious, reactogenic, and immunogenic properties of dry preparations of living attenuated parotitis vaccine].
July 1957, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
[Evaluation of the reactogenic and immunogenic properties of meningococcal vaccines].
November 1984, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
Biologic and immunogenic properties of the M-PK-L attenuated strain of Japanese B encephalitis virus.
February 1972, American journal of epidemiology,
V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
Studies on the immunogenic properties of tissue-culture sheep pox virus.
November 1965, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
[Oral pox vaccination. 3. Dose-response relationship following chicken pox drinking water vaccination using attenuated strain HP-1].
September 1972, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
[Reactogenic and immunogenic properties of whooping cough vaccines during inhalation immunization].
April 1962, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
[Immunogenic and reactogenic properties of Mycoplasma pneumoniae at different attenuation levels].
January 1970, Vestnik Akademii meditsinskikh nauk SSSR,
V I Lovlev, and L M Boĭchuk, and A T Kuz'micheva, and M V Ivanova, and A A Smorodintsev
IMMUNOGENIC AND REACTOGENIC PROPERTIES OF LIVE TISSUE CULTURE ANTI-MUMPS VACCINE.
November 1963, Acta virologica,
Copied contents to your clipboard!